Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
EWTX
Stock Latest News
The Fly
Edgewise Therapeutics rises 18.1%
1d ago
EWTX
Premium
The Fly
Cytokinetics report ‘arguably a best-case scenario’ for Edgewise, says Stifel
2d ago
CYTK
EWTX
Premium
The Fly
Cytokinetics Phase 3 data bodes well for Edgewise, says Raymond James
2d ago
CYTK
EWTX
Premium
The Fly
Edgewise Therapeutics rises 23.3%
2d ago
EWTX
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
23d ago
DYN
RNA
Premium
The Fly
JPMorgan ups Edgewise target, adds to Analyst Focus List
2M ago
EWTX
Premium
Company Announcements
Edgewise Therapeutics Completes Key Renal Study for EDG-7500, Setting Up Next Steps for Investors
2M ago
EWTX
Premium
The Fly
Edgewise Therapeutics’ sevasemten shows efficacy in Becker disorder
2M ago
EWTX
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
2M ago
AZN
BMY
Premium
Company Announcements
Edgewise’s New EDG-7500 Study Signals Broader Cardiovascular Ambitions
2M ago
EWTX
Premium
The Fly
Edgewise Therapeutics price target raised to $45 from $30 at Evercore ISI
2M ago
EWTX
Premium
The Fly
Edgewise Therapeutics reports Q4 EPS (47c), consensus (44c)
2M ago
EWTX
Premium
Pre-Earnings
EWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
EWTX
Premium
The Fly
Edgewise Therapeutics provides priorities for 2026
4M ago
EWTX
Premium
The Fly
Edgewise reports inducement grants as permitted by Nasdaq listing rules
4M ago
EWTX
Premium
Ratings
Edgewise Therapeutics: Advancing EDG-7500 in Hypertrophic Cardiomyopathy Underpins Buy Rating and Future Value Catalysts
4M ago
EWTX
Premium
The Fly
Edgewise Therapeutics rises 20.3%
4M ago
EWTX
Premium
Ratings
Edgewise Therapeutics: Differentiated EDG-7500 Profile, Late-Stage Cardiology Catalyst, and Expanding Pipeline Support Buy Rating
4M ago
EWTX
Premium
The Fly
H.C. Wainwright says Edgewise data reinforces EDG-7500 potential differentiation
4M ago
EWTX
Premium
Ratings
Prolonged Safety Uncertainty and Eroding Differentiation Keep EDG-7500 at Hold
4M ago
EWTX
Premium
The Fly
Stifel says longer-term questions remain after Edgewise’s EDG-7500 update
4M ago
EWTX
Premium
The Fly
Edgewise Therapeutics rises 15.5%
4M ago
EWTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
